Apellis Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Apellis Pharmaceuticals

Access the complete profile.

Apellis Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	44611 Pharmacies & Drug Stores 812 Personal & Laundry Services
Address	100 5th Avenue Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


Apellis Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Apellis Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Apellis Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Apellis Pharmaceuticals Annual Revenue and Growth Rate

Apellis Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Apellis Pharmaceuticals's revenues are gauged from an analysis of company filings.

Apellis Pharmaceuticals's Income Statement (based on Industry Averages)

Apellis Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Apellis Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
August 17, 2017	16	33%	$60 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Apellis Pharmaceuticals is developing and marketing. Apellis Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
G.A.LLERY Organization, production and presentation of exhibitions and displays in the nature of education pertaining to eye disease	10/12/2023
MAPVIZO Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders	07/28/2021
SYFOVRE Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders	07/28/2021

See all trademarks and details in the Full Report.

Market Share of Apellis Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Apellis Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Apellis Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Future Competition: Apellis Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Apellis Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)